Ideas to Action:

Independent research for global prosperity

X

Global Health Policy Blog

Feed

The WHO announced yesterday that 13 producers of single-drug artemisinin medicines for malaria have agreed to voluntarily phase them out in order to slow the progressions of drug resistance.

Related Topics:

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.